PSYCHOLOGICAL CARE AND HYPNOSIS IN PATIENTS WITH CANCER

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03971773

Enrollment

Registered

2019-06-03

Start date

2018-04-19

Completion date

2022-04-18

Last updated

2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypnosis and Cancer

Brief summary

The general aim of the research that we propose to implement is to study the potential benefits of hypnosis in the psycho-social care of patients with cancer. The main goal of this study is to measure the effects of hypnosis sessions on quality of life, anxiety and patient adjustment strategies. The effects of these interventions will be the subject of quantitative measurement via standardized scales in pre- and post-intervention situations of the potential effects of hypno-therapeutic intervention in cancer patients and

Interventions

OTHERhypnosis

patient with cancer will undergo sessions of hypnosis

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient with any kind of cancer and followed by a psychologist

Exclusion criteria

* Patient with neurological trouble * Patient with psychiatric decompassation

Design outcomes

Primary

Measure	Time frame	Description
quality of life scale	36 months	QLQC30 assessment

Secondary

Measure	Time frame	Description
anxiety scales	36 months	Edmonton Symptom Assessment System

Countries

France

Contacts

Primary ContactFlorence Duffaud, MD/PhD

florence.duffaud@ap-hm.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026